{
    "clinical_study": {
        "@rank": "131170", 
        "arm_group": [
            {
                "arm_group_label": "Incandescent red light source", 
                "arm_group_type": "Placebo Comparator", 
                "description": "A red, incandescent light source replaces all laser output. The treatment sessions are self-administered at home, every other day, for 16 weeks."
            }, 
            {
                "arm_group_label": "Handi-Dome Laser", 
                "arm_group_type": "Active Comparator", 
                "description": "Study subjects self-administer actual laser treatments, at home, every other day, for 16 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "This study will acquire data on hair growth of the head that is the result of treatment with\n      a non-heat generating, laser product.  This data will come from counting of terminal hairs\n      before treatment begins and after treatment is completed.  The treatment regime is every\n      other day for 16 weeks."
        }, 
        "brief_title": "A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy", 
        "completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Androgenetic Alopecia", 
        "condition_browse": {
            "mesh_term": [
                "Alopecia", 
                "Alopecia Areata"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to evaluate the efficacy of Low Level Laser Therapy product\n      that is configured in the novel design of a baseball cap, for promoting hair growth in\n      females diagnosed with genetic hair loss/female pattern hair loss."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Diagnosis of Androgenetic Alopecia / Female Pattern Hair Loss Fitzpatrick skin phototypes\n        of I - IV Ludwig-Savin Hair Loss scale I - II In overall good health as determined by the\n        physician investigator Active hair loss within the last 12 months Willingness to refrain\n        from using all other hair growth products or treatments -\n\n        Exclusion Criteria:\n\n        Photosensitivity to the specific wavelength of light - 650 nanometers. Malignancy in the\n        target treatment area Other forms of alopecia of the head Past medical history of a\n        collagen-vascular disease, thyroid disease or other cutaneous or systemic disease that\n        seriously affects the scalp.\n\n        In willingness to remove hair replacement products during the 16 weeks of therapy.\n\n        Using any medications deemed to inhibit hair growth as determined by the physician\n        investigator.\n\n        -"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "44", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01967277", 
            "org_study_id": "USC650"
        }, 
        "intervention": [
            {
                "arm_group_label": "Handi-Dome Laser", 
                "description": "One, 30 minute treatment, every other day for 16 weeks.", 
                "intervention_name": "Handi-Dome Laser", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "Incandescent red light source", 
                "description": "One, 30 minute treatment, every other day for 16 weeks.", 
                "intervention_name": "Incandescent red light source.", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 22, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Great Neck", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11021"
                    }, 
                    "name": "Bodian Dermatology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Woodbury", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "11797"
                    }, 
                    "name": "Center for Aesthetic Dermatology"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Novel Approach to Treating Androgenetic Alopecia in Females With Low Level Laser Therapy", 
        "overall_official": {
            "affiliation": "NST Consulting, LLC", 
            "last_name": "Raymond R. Blanche, BA", 
            "role": "Study Director"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Percentage Increase in Terminal Hair Counts from Pre-Treatment, Baseline for active test subjects over the placebo test subjects.", 
            "safety_issue": "No", 
            "time_frame": "16 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01967277"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Capillus, LLC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Capillus, LLC", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}